Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)

Por Hurt, CN, Jones, SEF, Madden, T‐A, Fiander, A, Nordin, AJ, Naik, R, Powell, N, Carucci, M, Tristram, A
Publicado no BJOG (2018)

A randomised, multi‐centre phase III study of 3 different doses of intravenous immunoglobulin 10...

Por Cornblath, David R., Hartung, Hans‐Peter, Katzberg, Hans D., Merkies, Ingemar S. J., van Doorn, Pieter A.
Publicado no J Peripher Nerv Syst (2018)

Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT...

Por Hypolite Muhindo Mavoko, DrPhD, Carolyn Nabasumba, MD, Raquel Inocêncio da Luz, PhD, Halidou Tinto, PhD, Umberto D'Alessandro, ProfPhD, Andrew Kambugu, MD, Vito Baraka, MSc, Anna Rosanas-Urgell, PhD, Pascal Lutumba, ProfPhD, Jean-Pierre Van geertruyden, PhD
Publicado em 2017-01-01

Pharmacokinetics and Safety of Famciclovir in Children with Herpes Simplex or Varicella-Zoster Virus Infection

Por Sáez-Llorens, X., Yogev, R., Arguedas, A., Rodriguez, A., Spigarelli, M. G., De León Castrejón, T., Bomgaars, L., Roberts, M., Abrams, B., Zhou, W., Looby, M., Kaiser, G., Hamed, K.
Publicado em 2009

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

Por Hochhaus, A, Saglio, G, Hughes, T P, Larson, R A, Kim, D-W, Issaragrisil, S, le Coutre, P D, Etienne, G, Dorlhiac-Llacer, P E, Clark, R E, Flinn, I W, Nakamae, H, Donohue, B, Deng, W, Dalal, D, Menssen, H D, Kantarjian, H M
Publicado no Leukemia (2016)

LB12. Safety and Efficacy of Fidaxomicin and Vancomycin in Pediatric Patients with Clostridium...

Por Wolf, Joshua, Kalocsai, Krisztina, Fortuny, Claudia, Lazar, Stefan, Bosis, Samantha, Korczowski, Bartosz, Petit, Arnaud, Bradford, Daniel, Incera, Elodie, Melis, Joost, Van Maanen, Rob
Publicado no Open Forum Infect Dis (2018)

Study protocol for an open-label, single-arm, multicentre phase II trial to evaluate the efficacy...

Por Iihara, Hirotoshi, Shimokawa, Mototsugu, Abe, Masakazu, Hayasaki, Yoh, Fujita, Yukiyoshi, Nagasawa, Yuki, Sakurai, Michiru, Matsuoka, Rie, Suzuki, Akio, Morishige, Kenichiro
Publicado no BMJ Open (2019)

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study

Por Piha-Paul, Sarina A., Taylor, Matthew H., Spitz, Daniel, Schwartzberg, Lee, Beck, J. Thaddeus, Bauer, Todd M., Meric-Bernstam, Funda, Purkayastha, Das, Karpiak, Linda, Szpakowski, Sebastian, Braiteh, Fadi
Publicado no Oncotarget (2019)

Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact...

Por Emery, Paul, Burmester, Gerd R, Naredo, Esperanza, Zhou, Yijie, Hojnik, Maja, Conaghan, Philip G
Publicado no BMJ Open (2018)

Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX...

Por Jacobson, Jeffrey M., Kuritzkes, Daniel R., Godofsky, Eliot, DeJesus, Edwin, Larson, Jeffrey A., Weinheimer, Steven P., Lewis, Stanley T.
Publicado em 2009

An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism

Por Nieschlag, Eberhard, Bouloux, Pierre-Marc G., Stegmann, Barbara J., Shankar, R. Ravi, Guan, Yanfen, Tzontcheva, Anjela, McCrary Sisk, Christine, Behre, Hermann M.
Publicado no Reprod Biol Endocrinol (2017)

Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa

Por Manaf, Asman, Tjandrawinata, Raymond R, Malinda, Desi
Publicado no Drug Des Devel Ther (2016)

Brain Tissue Oxygen Monitoring and Management in Severe Traumatic Brain Injury (BOOST-II): a Phase II Randomized Trial

Por Okonkwo, David O., Shutter, Lori A., Moore, Carol, Temkin, Nancy R., Puccio, Ava M., Madden, Christopher J., Andaluz, Norberto, Chesnut, Randall M., Bullock, M. Ross, Grant, Gerald A., McGregor, John, Weaver, Michael, Jallo, Jack, LeRoux, Peter D., Moberg, Dick, Barber, Jason, Lazaridis, Christos, Diaz-Arrastia, Ramon R.
Publicado no Crit Care Med (2017)

Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin’s lymphoma: A pilot study

Por Lum, LG, Thakur, A, Pray, C, Kouttab, N, Abedi, M, Deol, A, Colaiace, WM, Rathore, R
Publicado em 2013

OS2.3 Updated results of REGOMA: A randomized, multicenter, controlled open-label phase II clinical...

Por Lombardi, G, de Salvo, G, Rudà, R, Franceschi, E, Eoli, M, Faedi, M, Pace, A, Lolli, I, Rizzato, S, Germano, D, Pasqualetti, F, Farina, M, Magni, G, Bellu, L, Caccese, M, Pambuku, A, Bergo, E, Indraccolo, S, Gardiman, M, Soffietti, R, Zagonel, V
Publicado no Neuro Oncol (2018)

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Por Lindemann, Kristina, Malander, Susanne, Christensen, Rene D, Mirza, Mansoor R, Kristensen, Gunnar B, Aavall-Lundqvist, Elisabeth, Vergote, Ignace, Rosenberg, Per, Boman, Karin, Nordstrøm, Britta
Publicado em 2014

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53...

Por Chiappori, Alberto A., Williams, Charles C., Gray, Jhanelle E., Tanvetyanon, Tawee, Haura, Eric B., Creelan, Ben C., Thapa, Ram, Chen, Dung-Tsa, Simon, George R., Bepler, Gerold, Gabrilovich, Dmitry I., Antonia, Scott J.
Publicado no Cancer Immunol Immunother (2018)

VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study...

Por Beaton, Laura, Tregidgo, Henry F J, Znati, Sami A, Forsyth, Sharon, Clarkson, Matthew J, Bandula, Steven, Chouhan, Manil, Lowe, Helen L, Zaw Thin, May, Hague, Julian, Sharma, Dinesh, Pollok, Joerg-Matthias, Davidson, Brian R, Raja, Jowad, Munneke, Graham, Stuckey, Daniel J, Bascal, Zainab A, Wilde, Paul E, Cooper, Sarah, Ryan, Samantha, Czuczman, Peter, Boucher, Eveline, Hartley, John A, Lewis, Andrew L, Jansen, Marnix, Meyer, Tim, Sharma, Ricky A
Publicado no JMIR Res Protoc (2019)

Safety and efficacy of minimally invasive surgery plus recombinant tissue plasminogen activator...

Por Hanley, Daniel F., Thompson, Richard E., Muschelli, John, Rosenblum, Michael, McBee, Nichol, Lane, Karen, Bistran-Hall, Amanda J., Mayo, Steven W., Keyl, Penelope, Gandhi, Dheeraj, Morgan, Tim C., Ullman, Natalie, Mould, W. Andrew, Carhuapoma, J. Ricardo, Kase, Carlos, Ziai, Wendy, Thompson, Carol B., Yenokyan, Gayane, Huang, Emily, Broaddus, William C., Graham, R. Scott, Aldrich, E. Francois, Dodd, Robert, Wijman, Cristanne, Caron, Jean-Louis, Huang, Judy, Camarata, Paul, Mendelow, A. David, Gregson, Barbara, Janis, Scott, Vespa, Paul, Martin, Neil, Awad, Issam, Zuccarello, Mario
Publicado no Lancet Neurol (2016)

A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment...

Por Currow, David, Watts, Gareth John, Johnson, Miriam, McDonald, Christine F, Miners, John O, Somogyi, Andrew A, Denehy, Linda, McCaffrey, Nicola, Eckert, Danny J, McCloud, Philip, Louw, Sandra, Lam, Lawrence, Greene, Aine, Fazekas, Belinda, Clark, Katherine C, Fong, Kwun, Agar, Meera R, Joshi, Rohit, Kilbreath, Sharon, Ferreira, Diana, Ekström, Magnus
Publicado no BMJ Open (2017)